379 related articles for article (PubMed ID: 9434313)
1. Anti-inflammatory cytokine levels in patients with septic shock.
Kasai T; Inada K; Takakuwa T; Yamada Y; Inoue Y; Shimamura T; Taniguchi S; Sato S; Wakabayashi G; Endo S
Res Commun Mol Pathol Pharmacol; 1997 Oct; 98(1):34-42. PubMed ID: 9434313
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of interleukin-1 receptor antagonist (IL-1ra) and severity of illness in patients with burns.
Endo S; Inada K; Yamada Y; Kasai T; Takakuwa T; Nakae H; Kamei Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
J Med; 1996; 27(1-2):57-71. PubMed ID: 8863178
[TBL] [Abstract][Full Text] [Related]
3. Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass.
Gormley SM; McBride WT; Armstrong MA; McClean E; MacGowan SW; Campalani G; McMurray TJ
Cytokine; 2002 Jan; 17(2):61-5. PubMed ID: 11886172
[TBL] [Abstract][Full Text] [Related]
4. Relation between pro- and anti-inflammatory cytokines and the production of nitric oxide (NO) in severe sepsis.
Groeneveld PH; Kwappenberg KM; Langermans JA; Nibbering PH; Curtis L
Cytokine; 1997 Feb; 9(2):138-42. PubMed ID: 9071565
[TBL] [Abstract][Full Text] [Related]
5. Two types of septic shock classified by the plasma levels of cytokines and endotoxin.
Endo S; Inada K; Inoue Y; Kuwata Y; Suzuki M; Yamashita H; Hoshi S; Yoshida M
Circ Shock; 1992 Dec; 38(4):264-74. PubMed ID: 1292890
[TBL] [Abstract][Full Text] [Related]
6. Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.
Locker GJ; Kofler J; Stoiser B; Wilfing A; Wenzel C; Wögerbauer M; Steger GG; Zielinski CC; Mader R; Burgmann H
Eur Cytokine Netw; 2000 Sep; 11(3):391-6. PubMed ID: 11022123
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
8. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock.
Iglesias J; Marik PE; Levine JS;
Am J Kidney Dis; 2003 Jan; 41(1):62-75. PubMed ID: 12500222
[TBL] [Abstract][Full Text] [Related]
9. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
Hübel K; Mansmann G; Schäfer H; Oberhäuser F; Diehl V; Engert A
Cytokine; 2000 Dec; 12(12):1797-800. PubMed ID: 11097751
[TBL] [Abstract][Full Text] [Related]
10. Differences in the profiles of circulating levels of soluble tumor necrosis factor receptors and interleukin 1 receptor antagonist reflect the heterogeneity of the subgroups of juvenile rheumatoid arthritis.
Muzaffer MA; Dayer JM; Feldman BM; Pruzanski W; Roux-Lombard P; Schneider R; Laxer RM; Silverman ED
J Rheumatol; 2002 May; 29(5):1071-8. PubMed ID: 12022325
[TBL] [Abstract][Full Text] [Related]
11. Persistently elevated soluble tumor necrosis factor receptor and interleukin-1 receptor antagonist levels in critically ill patients.
Rogy MA; Coyle SM; Oldenburg HS; Rock CS; Barie PS; Van Zee KJ; Smith CG; Moldawer LL; Lowry SF
J Am Coll Surg; 1994 Feb; 178(2):132-8. PubMed ID: 8173722
[TBL] [Abstract][Full Text] [Related]
12. Functional modification of vascular endothelial cells by cytokines during septic shock.
Endo S; Inada K; Yamada Y; Takakuwa T; Nakae H; Kasai T; Koike S; Inoue Y; Niimi M; Wakabayashi G; Taniguchi S
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):23-38. PubMed ID: 8948012
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 13 and inflammatory markers in human sepsis.
Collighan N; Giannoudis PV; Kourgeraki O; Perry SL; Guillou PJ; Bellamy MC
Br J Surg; 2004 Jun; 91(6):762-8. PubMed ID: 15164448
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity.
Gabay C; Cakir N; Moral F; Roux-Lombard P; Meyer O; Dayer JM; Vischer T; Yazici H; Guerne PA
J Rheumatol; 1997 Feb; 24(2):303-8. PubMed ID: 9034987
[TBL] [Abstract][Full Text] [Related]
15. Early postoperative compensatory anti-inflammatory response syndrome is associated with septic complications after major surgical trauma in patients with cancer.
Mokart D; Capo C; Blache JL; Delpero JR; Houvenaeghel G; Martin C; Mege JL
Br J Surg; 2002 Nov; 89(11):1450-6. PubMed ID: 12390391
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokine inhibitors, TNF-alpha and oxidative burst of polymorphonuclear leukocytes in the pathogenesis of sepsis in newborns.
Sikora JP; Chlebna-Sokół D; Dabrowska I; Lipczyński D; Chrul S
Arch Immunol Ther Exp (Warsz); 2001; 49(2):155-61. PubMed ID: 11348020
[TBL] [Abstract][Full Text] [Related]
17. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
Sikora JP; Kuzański W; Andrzejewska E
Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
[TBL] [Abstract][Full Text] [Related]
18. Nitrite/nitrate oxide (NOx) and cytokine levels in patients with septic shock.
Endo S; Inada K; Nakae H; Arakawa N; Takakuwa T; Yamada Y; Shimamura T; Suzuki T; Taniguchi S; Yoshida M
Res Commun Mol Pathol Pharmacol; 1996 Mar; 91(3):347-56. PubMed ID: 8829774
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha is not essential in endotoxin induced eye inflammation: studies in cytokine receptor deficient mice.
Rosenbaum JT; Han YB; Park JM; Kennedy M; Planck SR
J Rheumatol; 1998 Dec; 25(12):2408-16. PubMed ID: 9858438
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
